Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) which have been generally used in diagnosis of CRC and other types of cancer, exhibited a less-than-desirable sensitivity and specificity3-5. This evidence concerns the gene CEACAM5 and cancer.